LNSR - LENSAR, Inc. Stock Price, Fair Value and News

3.26USD+0.08 (+2.52%)Market Closed

Market Summary

USD3.26+0.08

Market Closed

2.52%

LNSR Stock Price

View Fullscreen

LNSR RSI Chart

LNSR Valuation

Market Cap

37.1M

Price/Earnings (Trailing)

-2.58

Price/Sales (Trailing)

0.88

Price/Free Cashflow

-3.75

LNSR Price/Sales (Trailing)

LNSR Profitability

Operating Margin

50.06%

Return on Equity

-43.03%

Return on Assets

-20.67%

Free Cashflow Yield

-26.64%

LNSR Fundamentals

LNSR Revenue

Revenue (TTM)

42.2M

Rev. Growth (Yr)

18.31%

Rev. Growth (Qtr)

23.58%

LNSR Earnings

Earnings (TTM)

-14.4M

Earnings Growth (Yr)

-57.67%

Earnings Growth (Qtr)

-252.88%

Breaking Down LNSR Revenue

Last 7 days

6.5%

Last 30 days

-6.0%

Last 90 days

-9.4%

Trailing 12 Months

25.4%

How does LNSR drawdown profile look like?

LNSR Financial Health

Current Ratio

3.99

LNSR Investor Care

Shares Dilution (1Y)

2.63%

Diluted EPS (TTM)

-1.55

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	34.3M	38.2M	40.3M	42.2M
2022	36.8M	36.9M	36.3M	35.4M
2021	27.5M	30.4M	31.5M	34.5M
2020	29.5M	28.5M	27.4M	26.4M
2019	0	0	0	30.5M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of LENSAR, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Nov 22, 2023	winer gary m	bought	630	2.1	300	-
Nov 16, 2023	winer gary m	bought	2,125	2.125	1,000	-
Nov 15, 2023	winer gary m	bought	1,075	2.15	500	-
Nov 10, 2023	winer gary m	bought	2,135	2.135	1,000	-
Aug 11, 2023	winer gary m	bought	2,538	3.6	705	-
Aug 10, 2023	winer gary m	bought	3,660	3.66	1,000	-
May 25, 2023	lindstrom richard l md	acquired	-	-	9,288	-
May 25, 2023	weisner aimee s	acquired	-	-	9,288	-
May 25, 2023	link william j phd	acquired	-	-	9,288	-
May 25, 2023	mclaughlin john peter	acquired	-	-	9,288	-

Which funds bought or sold LNSR recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 23, 2024	Global Retirement Partners, LLC	unchanged	-	-1.00	3.00	-%
Apr 02, 2024	ST GERMAIN D J CO INC	sold off	-100	-263	-	-%
Mar 11, 2024	VANGUARD GROUP INC	unchanged	-	182,059	1,521,490	-%
Feb 16, 2024	Madison Avenue Partners, LP	sold off	-100	-742,654	-	-%
Feb 14, 2024	Park West Asset Management LLC	unchanged	-	468,588	3,916,060	0.38%
Feb 14, 2024	CITADEL ADVISORS LLC	added	12.56	7,716	35,409	-%
Feb 14, 2024	Royal Bank of Canada	reduced	-95.61	-2,000	-	-%
Feb 14, 2024	RBF Capital, LLC	unchanged	-	21,032	175,760	0.01%
Feb 14, 2024	MILLENNIUM MANAGEMENT LLC	sold off	-100	-158,279	-	-%

Are Funds Buying or Selling LNSR?

Are funds buying LNSR calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own LNSR

No. of Funds

Unveiling LENSAR, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	park west asset management llc	9.9%	1,115,686	SC 13G/A
Feb 13, 2024	curtis nicholas t	7.9%	906,808	SC 13G/A
Feb 09, 2024	dimensional fund advisors lp	5.9%	660,682	SC 13G/A
Dec 11, 2023	madison avenue partners, lp	0.4%	45,743	SC 13G/A
May 19, 2023	north run capital, lp	9.91%	1,100,592	SC 13D
Feb 14, 2023	silver point capital l.p.	4.4%	480,845	SC 13G/A
Feb 14, 2023	madison avenue partners, lp	6.1%	669,046	SC 13G/A
Feb 13, 2023	north run capital, lp	9.95%	1,096,406	SC 13G/A
Feb 10, 2023	dimensional fund advisors lp	6.1%	677,467	SC 13G/A
Feb 08, 2023	curtis nicholas t	7.4%	821,884	SC 13G/A

Recent SEC filings of LENSAR, Inc.

View All Filings

Date Filed	Form Type	Document
Mar 25, 2024	DEFA14A	DEFA14A
Mar 25, 2024	DEF 14A	DEF 14A
Mar 25, 2024	ARS	ARS
Mar 05, 2024	S-8	Employee Benefits Plan
Mar 04, 2024	8-K	Current Report
Mar 04, 2024	10-K	Annual Report
Feb 26, 2024	8-K	Current Report
Feb 14, 2024	SC 13G/A	Major Ownership Report
Feb 13, 2024	SC 13G/A	Major Ownership Report
Feb 09, 2024	SC 13G/A	Major Ownership Report

Peers (Alternatives to LENSAR, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	185.5B	40.1B	-2.82%	-2.78%	32.41	4.63	-8.12%	-17.45%
BDX	67.5B	19.5B	-3.26%	-10.41%	53.77	3.46	4.02%	-22.04%
ALGN	23.6B	3.9B	-1.72%	-10.74%	52.95	6.1	3.42%	23.09%
BAX	20.8B	14.8B	-2.03%	-9.90%	7.83	1.4	2.12%	209.17%
MID-CAP
HSIC	9.4B	12.3B	0.44%	-12.46%	22.62	0.76	-2.44%	-22.68%
ATR	9.2B	3.5B	-2.07%	18.57%	32.49	2.65	4.97%	18.89%
BIO	8.1B	2.7B	-18.49%	-36.41%	-12.74	3.04	-4.68%	82.43%
XRAY	6.4B	4.0B	-5.85%	-24.53%	-47.67	1.62	1.10%	85.84%
AXNX	3.4B	366.4M	-3.04%	14.62%	-560.04	9.28	33.86%	89.83%
PDCO	2.3B	6.6B	-3.54%	-1.62%	12.12	0.36	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-13.37%	-14.88%	-1.92	0.41	7.73%	-1066.14%
ANIK	384.6M	166.7M	3.23%	-3.00%	-4.65	2.31	6.67%	-456.34%
ANGO	235.1M	324.0M	11.39%	-31.43%	-1.22	0.73	-3.19%	-337.41%
APYX	52.0M	52.3M	18.11%	-48.10%	-2.78	0.99	17.61%	19.28%
AEMD	4.0M	3.7M	-12.07%	240.00%	-0.33	1.07	5.77%	8.23%

LENSAR, Inc. News

Latest updates

LENSAR, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3
Revenue	23.6%	12,105,000	9,795,000	12,012,000	8,252,000	10,232,000	7,748,000	8,038,000	9,340,000	11,222,000	8,272,000	7,922,000	7,043,000	8,284,000	7,145,000	5,047,000	5,906,000	6,987,000	8,068,000
Cost Of Revenue	41.4%	6,956,000	4,918,000	5,251,000	3,932,000	3,750,000	3,859,000	3,146,000	4,648,000	5,592,000	4,421,000	3,464,000	3,149,000	3,619,000	3,249,000	3,101,000	2,338,000	-	4,793,000
S&GA Expenses	24.6%	6,374,000	5,117,000	7,854,000	6,755,000	7,204,000	6,119,000	7,569,000	6,278,000	5,811,000	6,523,000	5,518,000	6,035,000	8,658,000	6,290,000	4,041,000	4,779,000	-	3,964,000
R&D Expenses	-4.2%	1,463,000	1,527,000	1,499,000	1,650,000	1,615,000	1,577,000	3,834,000	4,788,000	3,422,000	3,184,000	3,006,000	2,746,000	2,543,000	2,005,000	1,434,000	1,571,000	-	4,331,000
EBITDA Margin	-	-	-	-	-	-	-	-0.48	-0.49	-0.52	-	-	-0.67	-0.70	-0.48	-0.45	-0.42	-0.41	-
Interest Expenses	-	-	-	-	1,000	-	-	-	-	-	-	-	-	-	65,000	671,000	604,000	-	494,000
Income Taxes	-	-	-	-	-	-7,000	-	-	-	-	-	-	-	-	-	-	-	-	-
EBT Margin	-	-	-	-	-	-	-	-0.53	-0.53	-0.57	-	-	-0.72	-0.75	-0.55	-0.53	-0.49	-0.48	-
Net Income	-252.9%	-3,926,000	2,568,000	-8,753,000	-4,272,000	-2,490,000	-3,991,000	-6,759,000	-6,674,000	-3,902,000	-6,155,000	-4,362,000	-5,182,000	-6,828,000	-4,763,000	-4,497,000	-3,686,000	-2,468,000	-5,818,000
Net Income Margin	-6.2%	-0.34	-0.32	-0.51	-0.51	-0.56	-0.59	-0.64	-0.57	-0.57	-0.71	-0.70	-0.77	-	-	-	-	-	-
Free Cashflow	-54.0%	-525,000	-341,000	-2,325,000	-6,704,000	-4,815,000	-4,703,000	-2,800,000	-2,653,000	-895,000	-2,213,000	-1,482,000	-4,733,000	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet															(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2019Q4
Assets	-1.8%	70.00	71.00	71.00	52.00	56.00	55.00	59.00	60.00	66.00	68.00	72.00	74.00	79.00	81.00	35.00
Current Assets	-4.5%	46.00	49.00	49.00	30.00	34.00	32.00	35.00	39.00	45.00	47.00	52.00	53.00	58.00	60.00	17.00
Cash Equivalents	-17.3%	21.00	25.00	25.00	8.00	15.00	19.00	25.00	29.00	32.00	32.00	35.00	36.00	41.00	43.00	5.00
Inventory	-10.3%	16.00	17.00	18.00	16.00	12.00	8.00	6.00	4.00	6.00	10.00	12.00	13.00	13.00	14.00	8.00
Net PPE	40.9%	1.00	0.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00
Liabilities	8.1%	22.00	21.00	25.00	13.00	14.00	12.00	14.00	10.00	12.00	11.00	11.00	9.00	12.00	12.00	65.00
Current Liabilities	5.6%	12.00	11.00	11.00	10.00	11.00	10.00	11.00	8.00	9.00	8.00	8.00	6.00	8.00	8.00	8.00
Shareholder's Equity	-8.1%	33.00	36.00	33.00	39.00	42.00	43.00	45.00	50.00	55.00	57.00	62.00	64.00	67.00	69.00	-
Retained Earnings	-3.6%	-111	-107	-110	-101	-97.51	-95.02	-91.03	-84.27	-77.59	-73.69	-67.54	-63.17	-57.99	-51.16	-38.18
Additional Paid-In Capital	0.7%	145	144	143	141	139	137	136	134	132	131	129	127	125	120	8.00
Shares Outstanding	0.7%	11.00	11.00	11.00	11.00	11.00	10.00	10.00	10.00	11.00	9.00	9.00	9.00	-	-	-
Float	-	-	-	34.00	-	-	-	59.00	-	-	-	79.00	-	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																		(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3
Cashflow From Operations	-41.6%	-480	-339	-2,144	-6,696	-4,758	-4,701	-2,790	-2,607	-739	-2,149	-1,462	-4,619	-1,997	-55.00	-5,375	-6,364	-	-
Share Based Compensation	-30.4%	816	1,173	1,824	1,726	1,695	1,672	1,637	1,607	1,543	1,573	1,430	2,320	5,135	3,872	-	38.00	-	-
Cashflow From Investing	-198150.0%	-3,965	-2.00	-181	-8.00	-57.00	-2.00	-10.00	-46.00	-156	-64.00	-20.00	-114	-105	14.00	-142	-93.00	-	-
Cashflow From Financing	171.2%	146	-205	-	-	196	-1,200	-	-	191	-	-	-	-	37,927	7,690	4,384	-	-

LNSR Income Statement

2023-12-31

STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Revenue
Product and service revenue	$ 35,716	$ 29,443
Lease	6,448	5,915
Total revenue	42,164	35,358
Cost of revenue (exclusive of amortization)
Total cost of revenue	21,057	15,403
Operating expenses
Selling, general and administrative expenses	26,100	27,170
Research and development expenses	6,139	11,814
Amortization of intangible assets	1,097	1,148
Operating loss	(12,229)	(20,177)
Other (expense) income
Change in fair value of warrant liabilities	(2,852)
Other income, net	698	263
Net loss	(14,383)	(19,914)
Other comprehensive gain
Change in unrealized gain on investments	4
Net loss and comprehensive loss	$ (14,379)	$ (19,914)
Net loss per common share:
Basic	$ (1.31)	$ (1.96)
Diluted	$ (1.31)	$ (1.96)
Weighted-average number of shares used in calculation of net loss per common share:
Basic	10,971	10,159
Diluted	10,971	10,159
Product
Revenue
Product and service revenue	$ 31,643	$ 25,959
Cost of revenue (exclusive of amortization)
Total cost of revenue	13,902	8,910
Service
Revenue
Product and service revenue	4,073	3,484
Cost of revenue (exclusive of amortization)
Total cost of revenue	5,064	4,552
Lease
Cost of revenue (exclusive of amortization)
Total cost of revenue	$ 2,091	$ 1,941

LNSR Balance Sheet

2023-12-31

BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 20,621	$ 14,674
Short-term investments	3,443
Accounts receivable, net of allowance of $62 and $56, respectively	4,001	6,040
Notes receivable, net of allowance of $7 and $4, respectively	323	200
Inventories	15,689	11,740
Prepaid and other current assets	2,367	1,062
Total current assets	46,444	33,716
Property and equipment, net	679	563
Equipment under lease, net	7,459	6,316
Long-term investments	492
Notes and other receivables, long-term, net of allowance of $26 and $9, respectively	1,279	442
Intangible assets, net	11,025	12,122
Other assets	2,207	2,685
Total assets	69,585	55,844
Current liabilities:
Accounts payable	4,007	5,422
Accrued liabilities	5,717	4,700
Deferred revenue	1,349	768
Operating lease liabilities	559	531
Total current liabilities	11,632	11,421
Long-term operating lease liabilities	1,750	2,272
Warrant liabilities	8,457
Other long-term liabilities	570	167
Total liabilities	22,409	13,860
Commitments and contingencies (Note 10)
Stockholders’ equity:
Series A Redeemable Convertible Preferred Stock, par value $0.01 per share, 20 and no shares authorized at December 31, 2023 and 2022, respectively; 20 and no shares issued and outstanding at December 31, 2023 and 2022, respectively; aggregate liquidation preference of $20,000 and $0 at December 31, 2023 and 2022, respectively	13,747
Preferred stock, par value $0.01 per share, 9,980 and 10,000 shares authorized at December 31, 2023 and 2022; no shares issued and outstanding at December 31, 2023 and 2022
Common stock, par value $0.01 per share, 150,000 shares authorized at December 31, 2023 and 2022; 11,327 and 11,093 shares issued and outstanding at December 31, 2023 and 2022, respectively	113	111
Additional paid-in capital	145,203	139,381
Accumulated other comprehensive income	4
Accumulated deficit	(111,891)	(97,508)
Total stockholders’ equity	33,429	41,984
Total liabilities, redeemable convertible preferred stock, and stockholders' equity	$ 69,585	$ 55,844

About LENSAR, Inc.

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

CEO	Mr. Nicholas T. Curtis
WEBSITE	lensar.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	110

LENSAR, Inc. Frequently Asked Questions

What is the ticker symbol for LENSAR, Inc.? What does LNSR stand for in stocks?

LNSR is the stock ticker symbol of LENSAR, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of LENSAR, Inc. (LNSR)?

As of Wed Apr 24 2024, market cap of LENSAR, Inc. is 37.15 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of LNSR stock?

You can check LNSR's fair value in chart for subscribers.

What is the fair value of LNSR stock?

You can check LNSR's fair value in chart for subscribers. The fair value of LENSAR, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of LENSAR, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for LNSR so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is LENSAR, Inc. a good stock to buy?

The fair value guage provides a quick view whether LNSR is over valued or under valued. Whether LENSAR, Inc. is cheap or expensive depends on the assumptions which impact LENSAR, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for LNSR.

What is LENSAR, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Apr 24 2024, LNSR's PE ratio (Price to Earnings) is -2.58 and Price to Sales (PS) ratio is 0.88. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. LNSR PE ratio will change depending on the future growth rate expectations of investors.